Linda Woo

Linda Woo has a comprehensive work experience in the field of clinical operations and research. Linda is currently the Director of Clinical Operations at ALX Oncology, a position they have held since July 2023. Previously, Linda worked as an Associate Director at Rain Oncology from May 2022 to June 2023. Prior to that, they held the same role at GRAIL, Inc. from October 2019 to May 2022.

Linda also gained valuable experience at monARC Bionetworks, where they served as the Director of Clinical Operations from June 2019 to October 2019, and as the Associate Director of Clinical Operations from May 2018 to July 2019. Earlier in their career, they worked at Gilead Sciences, where they held positions such as Senior Clinical Trial Manager from January 2016 to May 2018, Clinical Trial Manager from January 2013 to January 2016, and Senior Clinical Research Associate from February 2011 to January 2013.

Before joining Gilead Sciences, Linda worked as a Senior Clinical Trial Coordinator at Biogen Idec from September 2007 to January 2011. Linda also gained experience as a Clinical Trial Coordinator at MedFocus for Biogen Idec from September 2007 to May 2008. Linda started their career as a Clinical Research Associate in Pediatric Oncology at New York Medical College from November 2004 to September 2007.

Linda Woo pursued their education in a methodical manner. From 2000 to 2004, they attended the University of Portland, where they earned a Bachelor of Science degree in Biology. Linda later pursued higher education at New York Medical College, where they obtained a Master of Public Health degree with a focus on Epidemiology, completing their studies from 2004 to 2007.